Skip to content
SEARCH icon
  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
Search

SEARCH FOR AN ARTICLE

  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
icon

      HomeBiotech

      Biotech

      FDA Roundup: March 4, 2025
      Biotech

      FDA Roundup: March 4, 2025

      March 5, 2025
      Global In Situ Hybridization Market to Grow at a CAGR of ~7% by 2032 | DelveInsight
      Biotech

      Global In Situ Hybridization Market to Grow at a CAGR of ~7% by 2032 | DelveInsight

      March 4, 2025
      CARsgen’s Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA
      Biotech

      CARsgen’s Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA

      March 3, 2025
      POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
      Biotech

      POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

      March 2, 2025
      New independent studies show that ColdZyme addresses the root cause of respiratory infections, reducing sick days and symptoms
      Biotech

      New independent studies show that ColdZyme addresses the root cause of respiratory infections, reducing sick days and symptoms

      March 1, 2025
      MAGic™ BioProcessing welcomes a new team member
      Biotech

      MAGic™ BioProcessing welcomes a new team member

      February 28, 2025
      Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer
      Biotech

      Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer

      February 27, 2025
      FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
      Biotech

      FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review

      February 26, 2025
      Year-end report: SciBase
      Biotech

      Year-end report: SciBase

      February 25, 2025
      NMPA Accepts NDA and Grants Priority Review Designation to Innovent’s Ipilimumab Injection, China’s First Domestic CTLA-4 Inhibitor, in Combination with Sintilimab as Neoadjuvant Treatment for Colon Cancer
      Biotech

      NMPA Accepts NDA and Grants Priority Review Designation to Innovent’s Ipilimumab Injection, China’s First Domestic CTLA-4 Inhibitor, in Combination with Sintilimab as Neoadjuvant Treatment for Colon Cancer

      February 24, 2025
      « 1 … 40 41 42 43 44 … 46 »

       

      LATEST NEWS

      • Investing News BlackRock Ups US Stocks Outlook
      • Investing News Goldman Shares Fall Amid Quarterly Results
      • Investing News Adidas Adjusts Profit Guidance Amid Challenges
      • Investing News Renk’s Impact Amid Middle East Tensions

      Bull Stock Research

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Bull Stock Research.

      I want e-mail alerts, updates, and offers and agree to the Bull Stock Research privacy policy.

      Market Jar Media Inc. © 2026